Chromogenic in situ Hybridization Compared with Real time Quantitative Polymerase Chain Reaction to Evaluate HER2/neu Status in Breast Cancer.

about

Chromogenic in situ Hybridization Compared with Real time Quantitative Polymerase Chain Reaction to Evaluate HER2/neu Status in Breast Cancer.

Item

http://www.wikidata.org/entity/Q55053588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@en

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@nl

type

Item

label

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@en

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@nl

prefLabel

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@en

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@nl

P1476

Chromogenic in situ Hybridizat ...... 2/neu Status in Breast Cancer.

@en

P2093

Arezoo Shajiei

http://www.w3.org/2001/XMLSchema#string

Azar Fani

http://www.w3.org/2001/XMLSchema#string

Ehsan Ghayoor Karimiani

http://www.w3.org/2001/XMLSchema#string

Fateme Homaee

http://www.w3.org/2001/XMLSchema#string

Hossein Ayatollahi

http://www.w3.org/2001/XMLSchema#string

Maryam Sheikh

http://www.w3.org/2001/XMLSchema#string

Sepideh Shakeri

http://www.w3.org/2001/XMLSchema#string

Seyyede Fatemeh Shams

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.

Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.

Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer.

Chromogenic in situ hybridization analysis of HER-2/neu status in breast carcinoma: application in screening of patients for trastuzumab (Herceptin) therapy.

Chromogenic and fluorescent in situ hybridization in breast cancer.

P304

128-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29515634

http://www.w3.org/2001/XMLSchema#string

P932

5831068

http://www.w3.org/2001/XMLSchema#string